Introduction
The use of non-steroidal anti-inflammatory drugs has been associated with hepatic disorders that mimic a range of liver diseases in patients with no previous exposure to these drugs, ranging from clinically asymptomatic increases in serum liver enzyme activity to mild reversible hepatitis and in rare instances to fatal acute fulminant hepatitis. ' The main clinical symptoms of acute liver injury in people who take these drugs are similar to those found in viral hepatitis-that is, nausea, vomiting, fatigue, tenderness of the right abdomen, loss of appetite, and jaundice. In some cases a systemic reaction with fever, pruritus, and cutaneous rash may be observed.
Only two epidemiological studies have specifically studied the incidence of liver disease associated with the use of non-steroidal anti-inflammatory drugs in a large population.2 3In the most recent Jick et al studied a cohort of 102 644 users and found that three of them had been admitted to hospital for serious liver disease. 3 To provide additional information on the role of nonsteroidal anti-inflammatory drugs in acute liver injury we carried out a retrospective cohort study to evaluate the clinical features and incidence of acute noninfectious liver injurv serious enough to require admission to hospital (with no other documented cause) in users of non-steroidal anti-inflammatory drugs by using the computerised databases of Saskatchewan Health in Canada. We also estimated the background incidence of admission for acute liver injury in the same population when they were not taking nonsteroidal anti-inflammatory drugs.
Subjects and methods
Over 95% of the 1 1 million residents of the province of Saskatchewan are entitled to receive medical benefits through the department of health. 4 As a byproduct of providing these health services, the Saskatchewan health plan has accumulated a large amount of medical care information on computerised databases over the past 20 years. This includes prescription data, outpatient and hospital diagnostic information, cancer and vital statistics, and records of special medical and supportive services. Most of these databases may be linked by a unique patient identifier. As a result a complete chronological profile of prescriptions, outpatient visits, and admissions to hospital is available for all patients included in the health plan. The population of the province is stable with low rates of immigration and emigration.
This study was part of a research project designed to look at the association between concurrent use of nonsteroidal anti-inflammatory drugs and several serious outcomes among the population from January 1982 to December 1986.' Any member of the health plan filling a prescription for one of five drugs (diclofenac, indomethacin, naproxen, sulindac, and piroxicam) entered the study population and was followed up until admission to hospital for hepatitis, death, departure from the health plan, or end of the study period.
The methods for classifying person time have been presented in detail elsewhere.' Briefly, subjects were categorised into current use of non-steroidal antiinflammatory drugs, which included the 60 days after a prescription, or no current use, which included all the remaining eligible person time of observation. Current use was further classified according to the most recent drug dispensed. Every prescription filled after the patient became a study member was identified. During the study 12 non-steroidal anti-inflammatory drugs were available only through prescription, and aspirin was available over the counter. Subjects could pass back and forth between the categories of use, determined by the dates on which the drugs were dispensed.
Periods of current use of non-steroidal antiinflammatory drugs were categorised according to the total preceding number of consecutive prescriptions that is, prescriptions that followed within 90 days of one another. Duration of use for patients exposed to the drugs was calculated as the total number of consecutive prescriptions filled before admission to hospital, and the daily dose was estimated according to the strength and quantity prescribed and the time interval between two consecutive prescriptions or index date, or both.
We identified the first admission to hospital for any of the following primary discharge diagnoses (International Classification of Diseases ninth revision (ICD-9) codes) from the hospital services plan database: acute and subacute necrosis of the liver (570), unspecified hepatitis (57313), and jaundice (782 4 (table II) .
The mean age of the cases in the group currently using the drugs was 66 (range 22-93) years and in the group not currently using the drug 60 (21-90) years. The onset of the liver injury (first symptoms noticed) began within 10 days before admission in 24 (71%) of the cases. One patient developed symptoms more than one month before admission. Two of the 34 patients BMJ VOLUME 305 admitted to hospital died. Table III presents The length of admission ranged from one to 34 days with 17 patients staying less than one week and seven patients staying two weeks or more. Of the six cases occurring among patients currently using nonsteroidal anti-inflammatory drugs with no concomitant use of other hepatotoxic drugs, only one had use of non-steroidal anti-inflammatory drugs as a cause of the liver injury recorded on the discharge summary. Of the 24 admissions when the patient had taken at least one other hepatotoxic drug, these drugs were thought by the treating physicians to account partially for the acute liver injury in 16 cases. The daily doses used were in line with the average recommended for the different non-steroidal anti-inflammatory drugs. There were 10 cholestatic liver injuries out of 16 in the group taking non-steroidal anti-inflammatory drugs compared with six out of 18 in the group not taking these drugs.
The crude rate ratio (95% confidence interval) associated with use of non-steroidal anti-inflammatory drugs was 2-3 (1 1 to 4 9). The figure for men was 3 1 (1-0 to 9 6) and for women 2-0 (0-8 to 4 5). There was no interaction between use and age, but the incidence of admission to hospital for acute liver disorders among people aged over 65 years was three times that among younger people (data not shown). The rate ratio adjusted for age and sex was 1-7 (0 8 to 3 7). Redefinition of current use of non-steroidal anti-inflammatory drugs as up to 90 days after the prescription did not materially change the rate ratio estimate, which was 2 5 (1 3 to 4 9). When the cases were restricted to those with no concomitant use of hepatotoxic drugs other than non-steroidal anti-inflammatory drugs the rate ratio was 4 0 (0 9 to 19-0) with the overall denominator being current use and no current use of non-steroidal anti-inflammatory drugs in person time. Table V presents the risk associated with duration of exposure to non-steroidal anti-inflammatory drugs. The rate ratio for people receiving only one prescription was 3-2 (0 9 to 9 0), which was similar to that for those receiving from two to nine consecutive prescriptions. There was no increased risk for long duration, defined as 10 or more consecutive prescriptions. 
Discussion
In this large, population based cohort study we found that subjects had twice the risk of newly diagnosed acute liver injury when they were taking non-steroidal anti-inflammatory drugs as when they were not taking these drugs. Sixteen cases of acute liver injury required hospital admission during the 177 550 person years of observation in the period immediately after prescriptions and 18 cases in the 467 906 person years when non-steroidal anti-inflammatory drugs had not been recently prescribed. The incidence in people currently using non-steroidal anti-inflammatory drugs was nine (6 to 15) cases per 100 000 person years. The excess risk associated with current use was five cases per 100 000 person years. There was an increased risk in both men and women. The risk of admission to hospital was strongly related to age, but the rate ratio associated with current use was the same across age groups. There was some indication that the relative risk was greater early in the course of treatment. For subjects receiving 10 or more prescriptions the risk was essentially the same as when not taking non-steroidal anti-inflammatory drugs. None of the patients were taking a daily dose larger than the maximum recommended dose for the particular drug, but five were exposed to two different non-steroidal antiinflammatory drugs in the 60 days before admission. The clinical signs and symptoms leading to admission were alike in the two groups. There was a predominance of cholestatic liver injury among patients currently using non-steroidal anti-inflammatory drugs, whereas the principal type of liver injury when not using these drugs was hepatocellular.
The evaluation of the effect of non-steroidal antiinflammatory drugs on chronic liver disease is an important task in the overall assessment of benefit and risk of these drugs but was beyond the scope of the present study. The main types of acute hepatic injuries are either cytotoxic (liver cell damage) or cholestatic (impairment of bile excretion)." Biochemical tests of the liver (alanine aminotransferase and aspartate aminotransferase) have been found to have inadequate sensitivity and specificity to predict serious clinical liver injury.' Most abnormal liver values found in the general population exposed to non-steroidal antiinflammatory drugs are transient and not followed by any serious liver injury.'7 Also, this study shares the limitations of any research that uses only hospital based BMJ VOLUME 305cases. All instances of self limiting liver injury not requiring admission would not have been detected. Severe liver disorders, on the other hand, may occur without early changes in standard liver function. '8 Acute liver injury associated with use of nonsteroidal anti-inflammatory drugs is considered to be the result of current rather than past exposure. Therefore we chose as the comparison group the same people who had taken non-steroidal anti-inflammatory drugs at a time when they were no longer taking the drugs.'9 We compared the incidence rate of acute liver injury during the total person time when subjects were taking non-steroidal anti-inflammatory drugs with the incidence rate during the total person time when they were not. The use of the exposed population as its own comparison group contributes to a reduction in confounding. Risk characteristics that do not change with time will necessarily be the same for exposed and nonexposed patients. We must, however, consider the possibility of changes in the use of non-steroidal antiinflammatory drugs when applying this kind of cross over study design. The decision to start or stop use may be influenced by the presence of prodromal symptoms of the acute liver injury. We could not directly assess the extent of bias related to the beginning of medication for early non-specific symptoms of liver injury not yet diagnosed. For the 12 current users, however, for whom information on the indication for use of nonsteroidal anti-inflammatory drugs was recorded, osteoarthritis was the underlying clinical condition. We evaluated the pattem of stopping treatment. Only four out of the 18 patients in the group not currently taking non-steroidal anti-inflammatory drugs had filled a prescription for non-steroidal anti-inflammatory drugs two to six months before admission to hospital; four had filled one prescription seven to 12 months before admission; and the remaining 10 had not filled a prescription in the year before admission.
Increasing the criterion for current use of non-steroidal anti-inflammatory drugs to up to 90 days after the prescription did not materially change the rate ratio estimate.
The effects if non-steroidal anti-inflammatory drugs can be seen most clearly in a population free of the "background noise" of hepatotoxicity induced by other drugs.2" In the subpopulation with no use of other hepatotoxic drugs the rate ratio estimate of the effect of non-steroidal anti-inflammatory drugs on acute liver injury was larger than in the overall' population.
Some of the patients did not undergo tests to rule out infectious hepatitis. In addition, diagnostic tests for hepatitis C were not available during the study, and differential diagnosis for cholelithiasis was not always carefully considered. All these limitations must be considered when interpreting our results, and some cases may have been misclassified. Any misclassification, however, would be similar in the two groups and may therefore have resulted in some underestimation of the true relative risk. Given the low incidence of acute liver injury, the impact on the excess risk would have been small. In summary, our results show that admissions to hospital for acute non-infectious liver injury are rare and that current use of non-steroidal anti-inflammatory drugs is associated with a twofold increase in the risk and an excess risk of five per 100 000 person years.
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(Accepted 30J7uly 1992) Correspondence to: Dr J Berth-Jones. BMAJ 1992; 305:868-9 Generalised pustular psoriasis: response to topical calcipotriol J Berth-Jones, J Bourke, K Bailey, R A C Graham-Brown, P E Hutchinson Pustular psoriasis is a life threatening disease' and usually requires treatment with systemic drugs which themselves carry significant risks. Calcipotriol, a vitamin D analogue, is an effective new topical treatment for psoriasis vulgaris.' This is the first report of its use in pustular psoriasis.
Case reports
Three consecutive patients admitted with pustular psoriasis were treated with calcipotriol ointment 50 ,ug/g (Dovonex).
Case I-A 68 year old woman had been controlling her psoriasis using tar and betamethasone valerate ointment until three weeks before admission. Her skin then deteriorated until 45% of her body surface was affected by erythema and pustulation. Calcipotriol ointment was applied twice daily. Within 24 hours pustulation had completely resolved. She continued to improve and was discharged after three weeks to continue using the same treatment. In total, 300 g calcipotriol ointment was applied during the admission.
